Table of Contents
HPB Surgery
Volume 2013, Article ID 298726, 7 pages
http://dx.doi.org/10.1155/2013/298726
Clinical Study

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma

1Department of Hepatobiliary Pancreatic Surgery, The Second People’s Hospital of Neijiang, Luzhou Medical College, Neijiang, Sichuan 641003, China
2Department of Cancer, The Second People’s Hospital of Neijiang, Luzhou Medical College, Neijiang, Sichuan 641003, China
3Department of Hepatobiliary Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

Received 16 February 2013; Revised 25 May 2013; Accepted 2 June 2013

Academic Editor: Attila Olah

Copyright © 2013 Hui Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hui Jiang, Chi Du, Mingwei Cai, et al., “An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma,” HPB Surgery, vol. 2013, Article ID 298726, 7 pages, 2013. https://doi.org/10.1155/2013/298726.